Bushra Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.49 M
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
- Revenue Growth 24.52%
- Profit Growth 55.85%
- Ebitda 58.13%
- Net Worth 6.22%
- Total Assets 19.06%
About Bushra Bio-Tech
Bushra Bio-Tech Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 August 2007 and has a history of 17 years and five months. Its registered office is in Amgaon, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹3.00 M.
Mohd Bhura and Rubina Bhura serve as directors at the Company.
Company Details
-
Location
Amgaon, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MH2007PTC173002
-
Company No.
173002
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Aug 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Bushra Bio-Tech Private Limited offer?
Bushra Bio-Tech Private Limited offers a wide range of products and services, including Common Disease Medicines, Psoriasis Ointment, Cosmetics, Hair & Beauty Products, Body Lotions, Herbal Body Care Cosmetics.
Who are the key members and board of directors at Bushra Bio-Tech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Bhura
|
Director | 27-Sep-2023 | Current |
|
Rubina Bhura
|
Director | 27-Sep-2023 | Current |
Financial Performance of Bushra Bio-Tech.
Bushra Bio-Tech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.52% increase. The company also saw a substantial improvement in profitability, with a 55.85% increase in profit. The company's net worth moved up by a moderate rise of 6.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bushra Bio-Tech?
In 2023, Bushra Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2014 | Bank Of India | ₹3.00 M | Open |
How Many Employees Work at Bushra Bio-Tech?
Unlock and access historical data on people associated with Bushra Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bushra Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bushra Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
